Tofacitinib 5 mg BID
A3921091
Phase 3 small_molecule completed
Quick answer
Tofacitinib 5 mg BID for Psoriatic Arthritis is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Psoriatic Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed